Mergers & Acquisitions

  • October 15, 2025

    Chancery 'Rewrote' $3.4B Merger Deal, J&J Tells Del. Justices

    Johnson & Johnson told the Delaware Supreme Court on Wednesday that the Chancery Court "rewrote" its $3.4 billion agreement for the acquisition of surgical robotics firm Auris Health, wrongly using the implied covenant of good faith and fair dealing to impose obligations the company never accepted.

  • October 15, 2025

    9th Circ. Lets Alaska Flyers Redo Hawaiian Merger Case

    The Ninth Circuit found that a lower court was right to toss a case from flyers and travel agents challenging the $1.9 billion merger between Alaska Airlines and Hawaiian Airlines but said they should have been given a chance to revise their allegations.

  • October 15, 2025

    Skadden, Kirkland Guiding Lone Star's $3.8B Hillenbrand Buy

    Skadden-led Hillenbrand Inc. will be acquired by an affiliate of Kirkland-advised Lone Star Funds in an all-cash transaction with an enterprise value of approximately $3.8 billion, the provider of industrial processing equipment said Wednesday. 

  • October 15, 2025

    Greenberg Traurig Lands Wilson Sonsini Life Sciences Pro

    Greenberg Traurig LLP has added a California partner from Wilson Sonsini Goodrich & Rosati with in-house and government legal experience to enhance its capacity to handle matters for clients in life sciences, artificial intelligence, biotechnology and other industries.

  • October 15, 2025

    Alston & Bird-Led TrueCar Goes Private In $227M Deal

    Automotive digital marketplace company TrueCar, advised by Alston & Bird LLP, on Wednesday revealed plans to go private after being bought by Perkins Coie LLP-led Fair Holdings in a $227 million deal.

  • October 15, 2025

    3 Firms Guiding S&P's Planned $1.8B Buy Of With Intelligence

    S&P Global Inc. said Wednesday it has agreed to acquire With Intelligence, a private markets data and analytics provider, from a group led by majority investor Motive Partners, for $1.8 billion.

  • October 15, 2025

    Novo Nordisk Licenses Omeros' Rare Disease Drug For $2.1B

    Denmark's Novo Nordisk SA said Wednesday that it will license an antibody from U.S. biopharma Omeros Corp. for up to $2.1 billion in order to expand its portfolio of therapies for rare diseases.

  • October 15, 2025

    BlackRock, Nvidia-Led Group Buying Aligned In $40B Deal

    The Artificial Intelligence Infrastructure Partnership, MGX and BlackRock's Global Infrastructure Partners said Wednesday they have agreed to acquire Aligned Data Centers from Macquarie Asset Management and co-investors, in a deal valuing Aligned at about $40 billion.

  • October 15, 2025

    Altice Rejects €17B Bid From French Telecoms Operators

    Telecoms group Altice France said Wednesday that it has "immediately rejected" a €17 billion ($19.8 billion) joint offer from French telecommunications operators Orange, Iliad and Bouygues Telecom for the majority of its domestic operations.

  • October 15, 2025

    Advent's $1.3B Bid For Chipmaker Wins Shareholder Backing

    U.S. private equity entity Advent said Wednesday that it has persuaded 67.55% of shareholders in Swiss chipmaker U-blox Holding AG to sell their stakes, signaling the success of its 1.03 billion Swiss franc ($1.3 billion) takeover offer.

  • October 14, 2025

    NC Court Denies Early Ruling In Hospital Antitrust Case

    Owners of a healthcare system in western North Carolina couldn't prevail in an early summary judgment attempt to avoid antitrust claims, after a North Carolina Business Court judge said the complexity of the request at hand precludes a "piecemeal" ruling.

  • October 14, 2025

    Freshfields Guides J&J's Planned Orthopedics Unit Spinoff

    Johnson & Johnson said Tuesday it intends to separate its orthopedics business into a stand-alone company within the next 18 to 24 months, with Freshfields LLP advising on the planned spinoff of the unit. 

  • October 14, 2025

    House of Doge To Go Public In Reverse Merger With Brag House

    House of Doge, led by Seward & Kissel LLP, will merge with esports platform Brag House Holdings Inc., which is being steered by Lucosky Brookman LLP, in a reverse merger backed by $50 million in capital investments that will see the cryptocurrency company go public.

  • October 14, 2025

    Catching Up With Delaware's Chancery Court

    Last week at the Delaware Chancery Court, Vice Chancellor Lori W. Will ruled that Carlos Vasallo remains the CEO of Caribevision TV Network LLC, finding that majority investors' attempt to remove him under a defective 2019 agreement was invalid for lack of proper notice.

  • October 14, 2025

    Covington, Sidley Guide $700M BioCryst Allergic Disease Deal

    BioCryst Pharmaceuticals Inc. will purchase Astria Therapeutics Inc., a biopharmaceutical company focused on therapies for allergic and immunologic diseases, in a cash and stock deal worth about $700 million, the companies announced Tuesday.

  • October 14, 2025

    Wachtell, Latham Steer $8.2B Timber Merger Of Equals

    Rayonier Inc. and PotlatchDeltic Corp. said Tuesday they have agreed to merge in an all-stock deal that will create an $8.2 billion entity and one of North America's largest publicly traded timber and wood products companies.

  • October 14, 2025

    Petershill To Sell Stake In VC Firm To Goldman Sachs

    Petershill Partners PLC said Tuesday that it has agreed to sell a majority of its stake in Industry Ventures to Goldman Sachs as a part of the global investment heavyweight's $965 million takeover of the venture capital investor.

  • October 14, 2025

    Malibu Life To Buy Texan Life Insurer TruSpire For $45M

    Malibu Life Holdings Ltd. said Tuesday that it will buy life and retirement insurance business TruSpire from Mutual of America Life Insurance Co. for $45 million to enter the U.S. direct annuity issuance business.

  • October 13, 2025

    Kirkland-Led Warburg Pincus To Buy Software Co. For €700M

    Private equity group Warburg Pincus LLC said Monday it has agreed to buy PSI, a German software company, for approximately €702 million ($812 million), to increase its presence in the growing global energy and industrial technology sector.

  • October 13, 2025

    7 Firms Guide €16B Merger Of UK, Greek Lottery Operators

    Allwyn International AG, the Swiss operator of the U.K. National Lottery and a Greek betting business said Monday that they would merge to form a multinational gambling group valued at €16 billion ($18.5 billion).

  • October 10, 2025

    Delta, Aeromexico Say USDOT Erred In Blocking Partnership

    Delta Air Lines and Aeromexico have asked the Eleventh Circuit to vacate the U.S. Department of Transportation's order terminating approval of their joint venture and ordering them to dismantle it by January, according to a petition for review posted to the case docket Friday.

  • October 10, 2025

    DOJ Can't Pause Review Of UnitedHealth Deal Amid Shutdown

    A Maryland federal judge rejected the U.S. Department of Justice's bid to stay its recently settled case with UnitedHealth over the company's merger with Amedisys because of the government shutdown and lapse in appropriations, ruling that a stay would impede the DOJ's ability to evaluate the public interest in the settlement.

  • October 10, 2025

    Seyfarth Eyes Middle-Market Bounce As Megadeals Dominate

    While multibillion-dollar mergers look good in headlines and have fueled some broader market optimism, Seyfarth attorneys told Law360 on Friday that the middle-market door has yet to fully swing open for a true mergers and acquisitions revival.

  • October 10, 2025

    4 Firms Build $972.6M Concrete Biz SPAC Merger

    Concrete Partners Holding LLC has unveiled plans to go public through a merger with special purpose acquisition company Haymaker Acquisition Corp. 4 in a deal that was built by four law firms and values the combined company at $972.6 million.

  • October 10, 2025

    Covington, Goodwin Guide Bristol Myers' $1.5B Orbital Buy

    Bristol Myers Squibb plans to acquire privately held Orbital Therapeutics for $1.5 billion in cash, aiming to expand its pipeline in cell- and RNA-based therapies for autoimmune diseases, the companies announced Friday.

Expert Analysis

  • 2 Del. Rulings Reinforce Proof Needed For Records Demands

    Author Photo

    Two recent Delaware Court of Chancery decisions involving Amazon and Paramount Global illustrate the significance of the credible basis standard on books and records requests, underscoring that stockholders seeking to investigate wrongdoing must come forward with actual evidence of misconduct — not mere allegations, say attorneys at Cleary.

  • How To Accelerate Your Post-Attorney Career Transition

    Author Photo

    Professionals seeking to transition to nonattorney careers may encounter skepticism as nontraditional candidates, but there are opportunities for thought leadership and to leverage speaking and writing to accelerate a post-attorney career transition, say Janet Falk at Falk Communications and Evgeny Efremkin at Toronto Metropolitan University.

  • Key Takeaways From The 2025 Spring Antitrust Meeting

    Author Photo

    Leadership changes, shifting priorities and evolving enforcement tools dominated the conversation at the recent American Bar Association Spring Antitrust Meeting, as panelists explored competition policy under a second Trump administration, agency discretion under the 2023 merger guidelines and new frontiers in conduct enforcement, say attorneys at Freshfields.

  • How Tariffs May Affect Proxy Contests This Season

    Author Photo

    While global tariffs imposed by the Trump administration will certainly chill at least some activity this proxy season, and make defending contests significantly easier, there will likely be many new activist investments once there is more economic certainty, meaning more proxy fights this fall, say attorneys at Sidley.

  • A Closer Look At New NYSE, Nasdaq Listing Rule Changes

    Author Photo

    The U.S. Securities and Exchange Commission has recently approved changes to the New York Stock Exchange's and the Nasdaq's listing rules on reverse stock splits, minimum share price requirements and required liquidity for initial listings, meaning listed companies facing delisting will have fewer means to regain compliance, say attorneys at Cahill Gordon.

  • Series

    Law School's Missed Lessons: Be An Indispensable Associate

    Author Photo

    While law school teaches you to research, write and think critically, it often overlooks the professional skills you will need to make yourself an essential team player when transitioning from a summer to full-time associate, say attorneys at Stinson.

  • 23andMe Case Highlights Privacy Complexities In Ch. 11

    Author Photo

    Attorneys at Pryor Cashman discuss the interplay between a sale of personally identifiable information and bankruptcy law in light of genetics and health company 23andMe's recent filing for Chapter 11 relief.

  • SEC Confidential Review Process Provides Issuers Flexibility

    Author Photo

    The U.S. Securities and Exchange Commission's recently announced enhancements to the process for confidentially submitting draft registration statements will be immediately impactful for issuers seeking to access the public capital markets, and should provide more grounds to explore and plan public offerings, say attorneys at Lowenstein Sandler.

  • Series

    Birding Makes Me A Better Lawyer

    Author Photo

    Observing and documenting birds in their natural habitats fosters patience, sharpens observational skills and provides moments of pure wonder — qualities that foster personal growth and enrich my legal career, says Allison Raley at Arnall Golden.

  • How Del. Law Rework Limits Corporate Records Requests

    Author Photo

    Newly enacted amendments to a section of the Delaware General Corporation Law that allows stockholders and beneficial owners to demand inspection of Delaware corporations' books and records likely curtails the scope of such inspections and aids defendants in framing motions to dismiss at the pleading stage, says Jonathan Richman at Brown Rudnick.

  • Series

    Adapting To Private Practice: From DOJ Leadership To BigLaw

    Author Photo

    The move from government service to private practice can feel like changing one’s identity, but as someone who has left the U.S. Department of Justice twice, I’ve learned that a successful transition requires patience, effort and the realization that the rewards of practicing law don’t come from one particular position, says Richard Donoghue at Pillsbury.

  • Issues To Watch At ABA's Antitrust Spring Meeting

    Author Photo

    Attorneys at Freshfields consider the future of antitrust law and competition enforcement amid agency leadership changes and other emerging developments likely to dominate discussion at the American Bar Association's Antitrust Spring Meeting this week.

  • Law Firm Executive Orders Create A Legal Ethics Minefield

    Author Photo

    Recent executive orders targeting BigLaw firms create ethical dilemmas — and raise the specter of civil or criminal liability — for the government attorneys tasked with implementing them and for the law firms that choose to make agreements with the administration, say attorneys at Buchalter.

  • Firms Must Embrace Alternative Billing Models Or Fall Behind

    Author Photo

    As artificial intelligence tools eliminate inefficiencies and the Big Four accounting firms enter the legal market, law firms that pivot from the entrenched billable hour model to outcomes-based pricing will see a distinct competitive advantage, says attorney William Brewer.

  • How Attorneys Can Master The Art Of On-Camera Presence

    Author Photo

    As attorneys are increasingly presented with on-camera opportunities, they can adapt their traditional legal skills for video contexts — such as virtual client meetings, marketing content or media interviews — by understanding the medium and making intentional adjustments, says Kerry Barrett.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Mergers & Acquisitions archive.